Mini Review

Published on 13 Apr 2022

Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review

in Pharmacology of Infectious Diseases

Shimaa M. Abdelgawad
Mahmoud A. El Hassab
Mohammed A. S. Abourehab
Eslam B. Elkaeed
Wagdy M. Eldehna

Frontiers in Pharmacology

doi 10.3389/fphar.2022.879118

15,214 views
26 citations

Review

Published on 12 Apr 2022

Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence

in Pharmacology of Infectious Diseases

Chuanhai Wang
Deqing Yang
Yifan Wang
Wentao Ni

Frontiers in Pharmacology

doi 10.3389/fphar.2022.896971

13,534 views
29 citations

Review

Published on 05 Apr 2022

Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge

in Pharmacology of Infectious Diseases

Maen Abdelrahim
Abdullah Esmail
Noor Al Saadi
Eva Zsigmond
Ebtesam Al Najjar
Doaa Bugazia
Hadeel Al-Rawi
Ayat Alsaadi
Ahmed O. Kaseb

Frontiers in Pharmacology

doi 10.3389/fphar.2022.848676

20,663 views
8 citations

Original Research

Published on 29 Mar 2022

Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials

in Pharmacology of Infectious Diseases

Andrés López-Cortés
Santiago Guerrero
Esteban Ortiz-Prado
Verónica Yumiceba
Antonella Vera-Guapi
Ángela León Cáceres
Katherine Simbaña-Rivera
Ana María Gómez-Jaramillo
Gabriela Echeverría-Garcés
Jennyfer M. García-Cárdenas

Frontiers in Pharmacology

doi 10.3389/fphar.2022.833174

6,271 views
7 citations

Original Research

Published on 25 Mar 2022

Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro

in Pharmacology of Infectious Diseases

Yuan-Chieh Yeh
Ly Hien Doan
Zi-Yi Huang
Li-Wei Chu
Tzu-Hau Shi
Ying-Ray Lee
Cheng-Tao Wu
Chao-Hsiung Lin
Shu-Tuan Chiang
Hui-Kang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.765553

13,078 views
44 citations

Original Research

Published on 22 Mar 2022

A Betulinic Acid Derivative, BA5, Induces G0/G1 Cell Arrest, Apoptosis Like-Death, and Morphological Alterations in Leishmania sp

in Pharmacology of Infectious Diseases

Tatiana Barbosa dos Santos Magalhães
Dahara Keyse Carvalho Silva
Jessica da Silva Teixeira
Juliana Dizaira Teles De Lima
José Maria Barbosa-Filho
Diogo Rodrigo Magalhães Moreira
Elisalva Teixeira Guimarães
Milena Botelho Pereira Soares

Frontiers in Pharmacology

doi 10.3389/fphar.2022.846123

2,464 views
8 citations

Review

Published on 10 Mar 2022

Aspirin in COVID-19: Pros and Cons

in Pharmacology of Infectious Diseases

Rana Zareef
Marwa Diab
Tala Al Saleh
Adham Makarem
Nour K. Younis
Fadi Bitar
Mariam Arabi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.849628

105,562 views
17 citations

Clinical Trial

Published on 10 Mar 2022

Riboflavin for COVID-19 Adjuvant Treatment in Patients With Mental Health Disorders: Observational Study

in Pharmacology of Infectious Diseases

R. A. Akasov
E. V. Khaydukov
D. S. Andreyuk
N. V. Sholina
A. N. Sheremeta
D. V. Romanov
G. P. Kostyuk
V. Ya. Panchenko
M. V. Kovalchuk

Frontiers in Pharmacology

doi 10.3389/fphar.2022.755745

6,287 views
10 citations

Perspective

Published on 03 Mar 2022

Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection

in Pharmacology of Infectious Diseases

Pascal Le Corre
Gwenolé Loas

Frontiers in Pharmacology

doi 10.3389/fphar.2022.849095

3,813 views
6 citations

Review

Published on 02 Mar 2022

Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize

in Pharmacology of Infectious Diseases

Majambu Mbikay
Michel Chrétien

Frontiers in Pharmacology

doi 10.3389/fphar.2022.830205

12,100 views
27 citations

Review

Published on 23 Feb 2022

Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance to Aminoglycoside Antibiotics

in Pharmacology of Infectious Diseases

Nuoyan Wang
Jing Luo
Fei Deng
Yasi Huang
Hong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.839808

21,844 views
76 citations

Original Research

Published on 07 Feb 2022

Evaluation of Bacteriophage Cocktail on Septicemia Caused by Colistin-Resistant Klebsiella pneumoniae in Mice Model

in Pharmacology of Infectious Diseases

Aprajita Singh
Alakh Narayan Singh
Nisha Rathor
Rama Chaudhry
Sudhir Kumar Singh
Gopal Nath

Frontiers in Pharmacology

doi 10.3389/fphar.2022.778676

4,468 views
17 citations

Original Research

Published on 04 Jan 2022

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens

in Pharmacology of Infectious Diseases

Xingchen Bian
Xiaofen Liu
Fupin Hu
Meiqing Feng
Yuancheng Chen
Phillip J. Bergen
Jian Li
Xin Li
Yan Guo
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.785893

4,909 views
11 citations

Original Research

Published on 14 Dec 2021

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

in Pharmacology of Infectious Diseases

Wei Yu
Yunbo Chen
Ping Shen
Jinru Ji
Chaoqun Ying
Zhiying Liu
Luying Xiong
Yunqing Qiu
Yonghong Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.771910

2,997 views
1 citation

Original Research

Published on 13 Dec 2021

Rational Designed Hybrid Peptides Show up to a 6-Fold Increase in Antimicrobial Activity and Demonstrate Different Ultrastructural Changes as the Parental Peptides Measured by BioSAXS

in Pharmacology of Infectious Diseases

Kai Hilpert
Jurnorain Gani
Christoph Rumancev
Nathan Simpson
Paula Matilde Lopez-Perez
Vasil M. Garamus
Andreas Robert von Gundlach
Petar Markov
Marco Scocchi
Ralf Mikut

Frontiers in Pharmacology

doi 10.3389/fphar.2021.769739

3,344 views
7 citations

Original Research

Published on 10 Dec 2021

Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study

in Pharmacology of Infectious Diseases

Jie Fang
Hui Li
Min Zhang
Guochao Shi
Mengying Liu
Yujie Wang
Xiaolan Bian

Frontiers in Pharmacology

doi 10.3389/fphar.2021.780940

5,340 views
29 citations

Navigation group

Articles

Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review

Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence

Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge

Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials

Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro

A Betulinic Acid Derivative, BA5, Induces G0/G1 Cell Arrest, Apoptosis Like-Death, and Morphological Alterations in Leishmania sp

Aspirin in COVID-19: Pros and Cons

Riboflavin for COVID-19 Adjuvant Treatment in Patients With Mental Health Disorders: Observational Study

Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection

Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize

Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance to Aminoglycoside Antibiotics

Evaluation of Bacteriophage Cocktail on Septicemia Caused by Colistin-Resistant Klebsiella pneumoniae in Mice Model

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

Rational Designed Hybrid Peptides Show up to a 6-Fold Increase in Antimicrobial Activity and Demonstrate Different Ultrastructural Changes as the Parental Peptides Measured by BioSAXS

Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study